Oman Pharmaceutical Products Co.LLC

Oman Pharma (OPP), headquartered in Muscat, is one of the most progressive pharmaceutical companies in the region, manufacturing and selling generics to more than 45 countries worldwide including the USA, Europe and other advanced markets. The company manufactures a wide variety of finished dosage formulations including cephalosporins, hormones, topical preparations, effervescent tablets, and solid and liquid oral dosage forms, with dedicated blocks for cephalosporins, hormonals and effervescent tablets; its manufacturing site in Salalah, Oman, is accredited by major regulatory authorities including the US FDA, EU-GMP, Health Canada, MOH Oman, TGA Australia, ANVISA Brazil, MCC South Africa, MOH Russia, GHC, MFDS Korea and JFDA Jordan.